Dr. Annalisa Jenkins, a biopharma expert with over 25 years of experience, has dedicated her career to combating rare diseases through innovative biotech ventures. She has a proven track record of leading teams from scientific discovery to global healthcare implementation and public market successes, exemplified by her leadership at Dimension Therapeutics. Committed to diversity, especially for women in science, Dr. Jenkins has held senior roles at Merck Serono and Bristol Myers-Squibb. Her career began as a medical officer in the British Royal Navy during the Gulf Conflict. Today, she serves on multiple company boards, supports major health organizations, and advises the FDA and academic institutions, continually advancing medical science and inclusive leadership.